Abnormal visual experience during childhood often leads to amblyopia, with strong links to binocular dysfunction that can include poor acuity in both eyes, especially in central vision. In animal models of amblyopia, the non-deprived eye is often considered normal and what limits binocular acuity. This leaves open the question whether monocular deprivation (MD) induces binocular dysfunction similar to what is found in amblyopia. In previous studies of MD cats, we found a loss of excitatory receptors restricted to the central visual field representation in visual cortex (V1), including both eyes' columns. This led us to ask two questions about the effects of MD: how quickly are receptors lost in V1? and is there an impact on binocular acuity? We found that just a few hours of MD caused a rapid loss of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor proteins across all of V1. But after a few days of MD, there was recovery in the visual periphery, leaving a loss of AMPA receptors only in the central region of V1. We reared animals with early MD followed by a long period of binocular vision and found binocular acuity deficits that were greatest in the central visual field. Our results suggest that the greater binocular acuity deficits in the central visual field are driven in part by the long-term loss of AMPA receptors in the central region of V1.
Introduction
Early visual experience shapes the maturation of circuits in visual cortex and development of visual perception. Abnormal experience during the critical period by depriving one eye of vision (monocular deprivation, MD) causes a loss of responsiveness in visual cortex (V1) to the deprived eye (Wiesel & Hubel, 1965a) , poor acuity through that eye (Dews & Wiesel, 1970) , and various binocular dysfunctions (Blake & Hirsch, 1975; Blake, Crawford, & Hirsch, 1974) . These changes are known as ocular dominance plasticity (Hubel, Wiesel, & LeVay, 1977) and just a few weeks of MD early in life can cause long-term loss of vision (Dews & Wiesel, 1970) . Often the visual deficits are restricted to the deprived eye, however, several studies of children with amblyopia have found contrast sensitivity and other vision deficits in both eyes (Birch, 2013; Chatzistefanou et al., 2005; Leguire, Rogers, & Bremer, 1990; Simons, 2005) , especially for vision in the fovea (Agervi, Nilsson, & Martin, 2010) .
Animal studies using MD typically describe changes in V1 effecting the deprived eye. But two recent studies have shown that the initial impact of MD on V1 is a loss of responsiveness in binocular excitatory neurons (Hengen et al., 2013; Kuhlman et al., 2013) followed by a transient reduction in activation of inhibitory interneurons (parvalbumin-positive, PV+) affecting responsiveness of both eyes (Kuhlman et al., 2013) . These studies show that the early phase of experience-dependent plasticity in V1 includes a loss of binocular responses.
PV+ inhibitory interneurons are an integral part of the neural circuitry that mediates experience-dependent plasticity in V1 (Hensch, 2014) . The input to PV+ neurons is dominated by aamino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors that contain GluA2/3 subunits (Kooijmans et al., 2014) . Furthermore, both rapid and long-term plasticity caused by MD involve changes in AMPARs and their trafficking proteins (Heynen et al., 2003; Yashiro et al., 2009; Yoon et al., 2009) including PICK-1 and Ube3A, are important mechanisms regulating experience-dependent synaptic plasticity (Colledge et al., 2003; Greer et al., 2010; Lee & Kirkwood, 2011; Sheng & Hyoung Lee, 2003; Yashiro et al., 2009) . AMPARs also mediate the main feedforward stimulus driven response of neurons in V1 (Self et al., 2012) . Monocular deprivation causes a loss of feedforward input to V1 neurons from the deprived eye (Ma, Li, & Tao, 2013) and in normal animals, the feedforward responses set up spatial tuning properties of V1 neurons (Lamme, Supèr, & Spekreijse, 1998) . Thus, AMPA receptors sit at a nexus connecting ocular dominance plasticity and feedforward tuning of V1 neurons that ultimately underlies visual acuity.
Previously, we studied the effect of MD in cats on expression of synaptic receptors in V1 and found a loss of AMPARs restricted to the region of V1 representing the center of vision (Beston, Jones, & Murphy, 2010) . Furthermore, anatomical investigation of another glutamate receptor (NMDA) found a central loss that included both eyes' ocular dominance columns (Murphy, Duffy, & Jones, 2004) . These results show that MD drives regional, as well as ocular dominance column plasticity changes in V1. Furthermore, since the loss of receptors affects both eyes' columns in the central region of V1 it raises the possibility that MD might affect binocular acuity.
Our earlier studies did not address how quickly AMPAR proteins are lost in the center of vision, or if the regional loss affects the vision of both eyes. We addressed these questions by studying the effect of various lengths of MD on expression of AMPARs (GluA2) and trafficking proteins (PICK-1 and Ube3A) in different regions of V1, and on long-term changes in binocular visual acuity.
Materials and methods

Animals and rearing conditions
To determine the effect of brief monocular deprivation (range 6 h-7 days) on AMPAR expression in V1 we used 5 animals, and to study changes in visual acuity after early monocular deprivation we used 17 animals. All experimental procedures were in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision research, and the Code of Ethics of the World Medical Association (Declaration of Helsinki), and approved by the McMaster University Animal Research Ethics Board. The animals used to examine rapid changes in AMPAR protein expression in V1 were studied at 5 weeks of age which is the peak of the critical period for ocular dominance plasticity in the cat (Olson & Freeman, 1980) and received either no deprivation, 6 h, 1 day, 4 days, or 7 days of monocular deprivation. Acuity measurements were made on animals reared with either normal vision (n = 3), or monocular deprivation for different durations during the critical period to create mild (deprivation from 4-6 weeks of age, n = 8), moderate (deprivation from eye opening to 5 weeks of age, n = 3), or more severe vision loss (deprivation from eye opening to 6 weeks of age, n = 3). After deprivation these animals were given about 3 months of binocular visual experience during which visual acuity was measured daily with both eyes open.
Monocular deprivation was done by suturing the eyelids closed with 5-0 vicryl using aseptic surgical techniques, gaseous anesthetic (isoflurane, 1.5-5%, in oxygen) for induction and maintenance of anesthesia, and following procedures that have been described previously (Murphy & Mitchell, 1987) . The sutured eyes were checked daily to ensure that the lid margins remained closed. At the end of deprivation the closed eye was re-opened by carefully parting the fused lid margins using aseptic surgical techniques.
2.2. Measurement and analysis of AMPAR subunit and receptor trafficking proteins -GluA2, PICK, Ube3A 2.2.1. Tissue collection Animals were euthanized with Euthanol (165 mg/kg), and perfused transcardially with cold 0.1 M phosphate buffered saline (PBS) (4°C; 80-100 ml/min). The brain was removed from the skull and immersed in ice cold PBS. A series of tissue samples (approx. 2 Â 2 mm) were taken from V1 as described previously (Beston, Jones, & Murphy, 2010) . For each cat, we used samples from V1 representing the center of vision (<5°, n = 2)), the visual periphery ($10-50°, n = 2-3), and the monocular field of vision (>60°, n = 1) region of V1 (Tusa, Palmer, & Rosenquist, 1978) . Each cortical tissue sample was rapidly frozen on dry ice and stored at À80°C. All tissue samples were taken from visual cortex contralateral to the deprived eye.
Tissue sample preparation
The tissue sample was suspended in cold homogenization buffer (1 ml buffer: 50 mg tissue, 0.5 mM DTT, 1 mM EDTA, 2 mM EGTA, 10 mM HEPES, 10 mg/L leupeptin, 100 nM microcystin, 0.1 mM PMSF, 50 mg/L soybean trypsin inhibitor) and homogenized using a glass-glass Dounce tissue homogenizer. Homogenized samples were suspended in 10% SDS, heated for 10 min, and then stored at À80°C. Protein concentrations were determined using bicinchoninic acid (BCA) assay guidelines (Pierce, Rockford, IL) and samples were diluted to a standard concentration of 1 lg protein/ml.
Immunoblotting
The samples (25 lg) were separated on polyacrylamide gels (SDS-PAGE) and transferred to polyvinylidene difluoride membranes (PVDF-FL) (Millipore, Billerica, MA). Each sample was run three times. Blots were pre-incubated in blocking buffer (Odyssey Blocking Buffer 1:1 with PBS) for 1 h (Li-cor Biosciences; Lincoln, NE), then incubated in primary antibody overnight at 4°C using the following concentrations: GluA2, 1:2000 (Invitrogen, Carlsbad, CA), Ube3A (E6AP), 1:2000 (Bethyl Laboratories, Montgomery, TX), PICK-1, 1:200 (NeuroMab, Davis, CA), b-Tubulin; 1:4000 (Imgenex, San Diego, CA). The blots were washed with PBS containing 0.05% Tween (Sigma, St. Louis, MO) (PBS-T) (3 Â 10 min), incubated (1 h, room temperature) with the appropriate IRDye labeled secondary antibody (Anti-Mouse, 1:8000, Anti-Rabbit, 1:10,000) (Li-cor Biosciences; Lincoln, NE), and washed in PBS-T (3 Â 10 min). The bands were visualized using the Odyssey scanner (Li-cor Biosciences; Lincoln, NE) then the blots were stripped and reprobed so that each blot was probed with each of the antibodies (Blot Restore Membrane Rejuvenation kit, Chemicon International, Temecula, CA).
Band analysis
To analyze the bands we scanned the blots (Odyssey Infrared Scanner) and quantified the bands using densitometry (Licor Odyssey Software version 3.0; Li-cor Biosciences; Lincoln, NE). Density profiles were determined by performing a subtraction of the background, integrating the pixel intensity across the area of the band, and dividing the intensity by the width of the band to control for variations in band size. b-tubulin normalization was used as the loading control, and for each sample, expression of the synaptic proteins was divided by b-tubulin expression. We verified that btubulin expression did not vary across conditions (all p values were n.s.) and thus was an appropriate loading control (Fig. 1) . A control sample, made by combining a small amount from each sample, was run on each gel so the density of each sample was quantified relative to the control (sample density/control density).
Statistical analysis
We made scatterplots showing all 3 runs (gray symbols) and average expression level for each animal (black symbols). All results were plotted as a percentage of the average expression for a normal 5 week old animal. We used a bootstrapping test to evaluate whether monocular deprivation caused a significant change in protein expression. Bootstrapping is a common statistical method for small sample sizes when parametric statistical methods are not appropriate. We used Matlab (The MathWorks, Inc., Natick, MA) to simulate a normally distributed data set with the same mean and standard deviation as the experimental results from normal animals. To determine if monocular deprivation caused a significant change, we compared the simulated normal data set with average protein expression for each length of monocular deprivation (6 h, 1 day, 4 days, or 7 days). We ran Monte Carlo analyses that randomly sampled from the simulated normal distribution N times, where N was the number of measurements made for each length of deprivation, region of V1, and antibody (N ranged from 2 to 9). This random sampling was repeated 1,000,000 times to create the normal distribution expected for those sample sizes (N). We used those simulations to calculate confidence intervals (CI) around the normal data and included those on each scatterplot. Deprivation conditions were identified as significantly less than normal (p < 0.05) when their average expression was less than 95% of the normal distribution and outside the normal CI range.
Curve-fitting
To describe the time course of changes in protein expression as a function of the length of monocular deprivation we used a model fitting approach (Christopoulos & Lew, 2002) . Single-or double-exponential decay functions [y ¼ yo þ a Ã expðÀt Ã bÞ þc Ã exp ðÀt Ã dÞ; where t = length of monocular deprivation in days] were fit using the results from all samples and the on-line curve-fitting tool zunzun.com. The best fitting curve was found by least squares analysis, and the goodness-of-fit (R) and statistical significance of the fit (p) was calculated. The time constants (s) for each phase of the decay function were calculated and 3s was used to describe the length of time for loss (3s loss ) or recovery (3s recovery ) of protein expression.
Principal component analysis
To assess the factors that affect the pattern of changes in AMPAR proteins we ran a multivariate analysis using principal component analysis (PCA). Protein expression was compiled into an m Â n matrix, where the rows (m = 3) represent the AMPAR proteins (GluA2, PICK-1, Ube3A), and the columns (n = 26) represent all of the samples from the 5 animals (central = 10, peripheral = 11, monocular = 5). The data were centered by subtracting the mean column vector, and then singular value decomposition (SVD) was applied to calculate the principal components in Matlab (The MathWorks, Inc., Natick, MA). The SVD represents expression of all proteins for each sample as a vector in high dimensional space. The PCA identifies the directions in ''protein expression space'' that represents the all the variance in the data.
Visual acuity measurement and analysis
Measurement of visual acuity
Daily measurements of visual acuity were made using the jumping stand procedure and started at 6 weeks of age after all deprived animals had finished their period of MD and both eyes were open (Giffin & Mitchell, 1978; Murphy & Mitchell, 1987 , 1991 . The target stimulus was a high contrast (Michelson contrast 0.86) sine-wave grating displayed on a computer monitor (Sony GDMFW900, 24 00 , 0.23 mm dot pitch, 2304 Â 1440 pixels, 8 bit gamma correction, 80 Hz frame rate) at a luminance of $40 cd/ m 2 . For each trial, 2 stimuli were displayed on either side of a center divider, the target sine-wave grating and a scrambled version of the grating. Cats viewed the stimuli from the jumping stage above the landing platform and jumped down to the right or left side to indicate their selection. The viewing distance was varied from 50-85 cm. Both the grating and scrambled stimuli were presented in a circular aperture that was either 4°, 8°, or 16°in diameter. The largest size aperture (16°) was used to measure development of binocular grating acuity until mature levels were reached at about 110 days of age. Acuity measurements with the smaller stimuli were only made after grating acuity had reached mature levels.
A two-alternative forced-choice paradigm and modified staircase procedure were used to measure acuity thresholds. Training began between 5 and 6 weeks of age and animals learned the task by first viewing an easy target stimulus (0.1 cycles/deg. sine-wave grating) and were trained to jump to the target stimulus. Correct jumps were rewarded with food (chicken liver) and petting, while incorrect jumps resulted in withholding the rewards and immediately repeating the trial. The animals learned to jump toward the target stimulus and met criteria of 10 consecutive correct jumps to the easy stimulus within a few sessions (3-5 sessions). After this brief learning period, binocular visual acuity thresholds were measured (5 sessions/week) for 10-12 weeks until the animals were about 110 days of age. Sessions were typically 45-60 min long and $45 trials were needed to obtain a grating acuity threshold.
Each testing session began with an easy target and the position of the 2 stimuli were interchanged from left to right in a pseudorandom order. Thresholds were determined using a staircase procedure where the spatial frequency of the grating was increased in small steps, 16 steps per octave. Using these small steps, performance was nearly error free until the spatial frequency approached the threshold level. Typically, performance fell from flawless to chance in just 2 steps providing a reliable measure of acuity thresholds. Animals usually received only 1 trial for easy stimuli unless an error was made. When an error was made, additional trials were given until the animal made either 5 consecutive correct responses, or 7 correct responses in a maximum of 10 trials. The minimum number of trials was increased to 3 for stimuli close to threshold. Sessions ended when the animal no longer achieved criterion within 10 trials. For each session the last spatial frequency passed was taken as the acuity threshold.
After binocular acuity thresholds stabilized at adult levels ($110 days of age) we measured monocular thresholds by placing an opaque contact lens (EyeTech Optics, Coquitlam BC) in one eye. We also measured grating acuity in the central visual field using smaller diameter stimuli (4°and 8°) and the same procedures described above. Both binocular and monocular acuities for the smaller stimuli were determined by measuring thresholds in 3-5 separate sessions.
Curve-fitting of acuity measurements
The development of binocular grating acuity measured with the 16°stimulus was quantified by fitting a sigmoid function to the thresholds from each animal [y ¼ a þ ððb À cÞ=ð1 þ ðt=cÞ^dÞÞ] where t = age (days). We used the age when the function reached 90% of asymptotic level as the time when adult acuity was attained. The average age and SEM was calculated for each group. There was a lot of overlap for individual functions within the normal and 2 weeks deprived groups so we also fit separate sigmoid functions to all of the data from normal animals and animals deprived for 2 weeks. The final binocular grating acuity, standard deviation, and 95% confidence interval (95% CI) for each animal were calculated using the last 10 acuity thresholds. Average binocular and deprived eye (monocular for normals) grating acuities and SEMs were determined for each of the 3 different stimulus sizes (4°, 8°, or 16°in diameter).
Statistical analyses
We used the same bootstrapping test described above to evaluate the significance of final acuities for each deprived animals compared to normals. A distribution of normal visual acuities was simulated with the same mean and standard deviation as the last 10 acuity measurements from the normal animals. We ran a Monte Carlo analysis that randomly sampled 10 times from the simulated normal acuity distribution then repeated that 1,000,000 times to create a distribution of normal acuities for a sample size of 10 thresholds. We calculated the probability that the acuity of deprived animals was from that simulated distribution of normal acuities and the z-score for the magnitude of the difference in deprived acuity away from the average acuity for normal animals.
To determine if there were differences among the 4 groups in the day-to-day variability in acuity we ran a repeated measures ANOVA using the last 10 binocular acuity thresholds measured with the 16°stimulus. Separate repeated measures ANOVAs were run to determine the effect of stimulus size on visual acuity thresholds. Post-hoc analyses were done using Tukey HSD. In addition, the effect of stimulus size was quantified by fitting linear functions using least squares to binocular and deprived eye (monocular for normal animals) acuities, then the slopes were compared using an ANCOVA.
Results
Analysis of AMPAR subunit and trafficking proteins -GluA2, PICK, Ube3A
We used b-tubulin as the loading control and verified that it was not affected by MD. Expression of b-tubulin was not different from normal animals after any length of deprivation (6 h, 1 day, 4 days, 7 days MD) or region of V1 (central, peripheral, monocular) ( Fig. 1A-C; all p values n.s.).
Monocular deprivation causes transient loss of AMPAR proteins in the visual periphery and monocular regions of V1 but sustained loss in the center of vision
To examine how quickly the loss of AMPAR proteins occurs in V1 we quantified expression of GluA2, PICK-1 and Ube3A after different lengths of MD (6 h, 1 day, 4 days, 7 days) and in 3 regions of V1 representing the center of vision (<5°, central), visual periphery ($10-$50°, peripheral), and monocular crescent (>60°, monocular) (Fig. 2) . We included the AMPAR trafficking proteins, PICK-1 and Ube3A, because they are involved in movement of AMPARs in and out of the synapse and their expression provides additional information about AMPAR dynamics that may differ from experience-dependent changes in expression of the AMPAR subunit GluA2.
We found that after 6 h of MD all regions of V1 had a rapid loss of the 3 AMPAR proteins. With longer deprivation there was recovery of expression but only in the visual periphery and monocular regions (Fig. 2D-I) . The changes in expression of the 3 AMPAR proteins were well fit by single-or double-exponential decay functions from which we calculated the amount of change from normal levels of expression and the time constants to quantify the rate of rapid loss (3s loss ) and subsequent recovery (3s recovery ) of protein expression.
In the central region in V1, just 6 h of MD caused a rapid loss of the 3 AMPAR associated proteins which dropped $30-40% below normal levels (GluA2 40% p < 0.001, PICK-1 30% p < 0.01, Ube3A 40% p < 0.001) ( Fig. 2A-C) . That loss persisted in the central region after longer MD and remained $30-40% below normal levels after 7 days of MD (GluA2, PICK-1, Ube3A, all p < 0.001). The time constants for the curve fits to each protein showed that the loss happened very quickly, within 5-7 h of MD ( Fig. 2A, GluA2 curve-fit R = 0.64, p = 0.0001, 3s loss = 7 h; Fig. 2B , PICK-1, curve-fit R = 0.58, p = 0.008, 3s loss = 7.1 h; Fig. 2C , Ube3A, curve-fit R = 0.61, p = 0.0003, 3s loss = 5 h).
In the visual periphery, 6 h of MD also caused a rapid loss of the AMPAR proteins which fell to $40-50% below normal (GluA2 50% p < 0.001, PICK-1 50% p < 0.001, Ube3A 40% p < 0.001) (Fig. 2D-F) . In contrast to the central region, the loss in the periphery was transient and after longer MD there was recovery of AMPAR protein . Gray dots are results from all runs, and black dots are the average for each kitten. Example bands are shown above the graphs. Single or double exponential decay functions were fit to describe changes in expression. 95% confidence intervals are displayed around the normal distribution. In the central region, GluA2, PICK-1, and Ube3A expression fell rapidly (30-40%) after 6 h of MD, and persisted for 7 days MD (all p values <0.001) (A, B, C). In the peripheral region, GluA2, PICK-1, and Ube3A expression fell rapidly (40-50%) after 6 h MD, and either completely recovered (GluA2, p = 0.4) or partially recovered (PICK-1, p < 0.05, Ube3A, p < 0.01) after 7 days MD (D, E, F). In the monocular region, GluA2, PICK-1, and Ube3A expression fell rapidly (50-70%) after 6 h of MD, and either completely recovered (GluA2, p = 0.2, PICK-1, p = 0.3) or partially recovered (Ube3A, p < 0.05) (G, H, I). Levels of significance are indicated by asterisks:
⁄ p < 0.05, ⁄⁄ p < 0.01. ⁄⁄⁄ p < 0.001. expression ( Fig. 2D-F) . The extent of recovery was variable and after 7 days MD some samples had normal or above normal levels, while other samples remained below normal. On average, however, GluA2 recovered to levels that were not different from normal (n.s.), while PICK-1 (p < 0.05) and Ube3A (p < 0.01) remained $15-20% below normal levels. Curve fits to those data showed a pattern of rapid loss (range for 3s loss 6.6-9.5 h of MD), similar to that found for the central region, followed by slow recovery (range for 3s recovery 10.7-27.7 days of MD) after longer MD (Fig. 2D , GluA2, curve-fit R = 0.56, p = 0.0006, 3s loss = 8.6 h, 3s recovery = 12.2 -days; Fig. 2E , PICK-1, curve-fit R = 0.6, p = 0.003, 3s loss = 6.6 h, 3s recovery = 27.7 days; Fig. 2F , Ube3A, curve-fit R = 0.5, p = 0.004, 3s loss = 9.5 h, 3s recovery = 10.7 days). The timing of the transient loss and subsequent recovery was similar to physiological changes found in rodent visual cortex (Kuhlman et al., 2013) . The monocular region also had a transient loss of the 3 AMPAR proteins after 6 h and 1 day of MD (Fig. 2G-I) . The transient loss in the monocular region was greater than in central or peripheral regions, and fell by $65-75% of normal levels (GluA2 70% p < 0.001, PICK-1 75% p < 0.001, Ube3A 65% p < 0.001). With longer MD (4 or 7 days) there was substantial recovery so that after 7 days of MD the levels for the 3 AMPAR proteins were either not different from normal or slightly below normal levels (GluA2 10% n.s., PICK-1 10% n.s., Ube3A 20% p < 0.05). The curve fits showed that the monocular region had a slightly more prolonged period of protein loss (range for 3s loss 11.4-19.6 h of MD) than the central or peripheral regions, but faster recovery (range for 3s recovery 4.9-9.6 days of MD) for all 3 AMPAR proteins (Fig. 2G, GluA2 , curve-fit R = 0.84, p < 0.0001, 3s loss = 17.7 h, 3s recovery = 9.6 days; 2H, PICK-1, curvefit R = 0.96, p < 0.0001, 3s loss = 11.4 h, 3s recovery = 8.3 days; 2I, Ube3A, curve-fit R = 0.78, p = 0.0006, 3s loss = 19.6 h, 3s recovery = 4.9 days).
Principal component analysis showed that MD has regional effects on AMPAR protein expression
The effect of different lengths of MD on expression of GluA2, PICK-1, and Ube3A was very similar within each region but different across regions in V1. That observation suggested that MD has different effects on plasticity for the center of vision where there was sustained loss versus the visual periphery or monocular regions where the loss was transient. Since we measured multiple AMPAR proteins and regions in V1 we used a multidimensional analysis to determine what factors accounted for the variance in the data. We took a data driven approach, and analyzed the expression of GluA2, PICK-1 and Ube3A in the different regions of V1 using principal components analysis (PCA). First, a 3 Â 26 matrix of protein expression was made where the 3 rows were the proteins (GluA2, PICK-1, Ube3A) and the 26 columns were the samples from all regions and animals. The data were centered by subtracting the mean column vector, and singular value decomposition (SVD) was applied to calculate the principal components. The first principal component accounted for the largest variation in the data and for this dataset the eigenvalue for PCA1 explained 88.4% of the variance, PCA2 explained 7.3%, and PCA3 explained 4.3% (Fig. 3A) . Only PCA1 met the Guttman-Kaiser criterion (an eigenvalue >1) to be used for further analysis (Jackson, 2005) .
The next step was to determine potential biological factors for PCA1. We plotted the basis vector for PCA1 (Fig. 3B) and found that the weights for GluA2, PICK-1 and Ube3A were positive and had similar amplitudes. Those weights suggested that the main factor underlying PCA1 was the variance in total protein expression, which was supported by a very strong correlation between PCA1 and the sum of GluA2, PICK-1, and Ube3A, that we called total protein (R = 0.99, p < 0.0001). We plotted total protein expression as a function of the different lengths of MD for the 3 regions in V1 (Fig. 3C) . Total AMPAR protein levels dropped in the 3 regions within 6 hours and in the monocular region it continued to fall reaching a minimum after about 1 day of MD. Interestingly, the levels of total protein expression in the 3 regions were very similar after 4 days of MD but after a few more days of MD there was recovery in peripheral and monocular regions. This analysis clearly illustrates the rapid transient loss of AMPAR proteins in all of V1 with subsequent recovery in visual periphery and monocular regions, and only the center of vision was left with sustained loss. The sustained loss after 1 week of MD was similar to the results from our previous study using longer MD (Beston, Jones, & Murphy, 2010) and led us to ask if this pattern of experience-dependent changes in AMPAR proteins in V1 is reflected in the impact of MD on visual acuity.
Development of binocular visual acuity after MD
To assess whether early MD has a long-term impact on development of binocular acuity we made daily measurements of grating acuity in normal and monocularly deprived animals. The animals were MDed for either 2 weeks (from 4-6 weeks of age), 5 weeks (eye opening to 5 weeks), or 6 weeks (eye opening to 6 weeks) to create a range of vision deficits from mild to more severe. Then binocular grating acuity measurements were started once the deprived eye was opened and continued until $4 months of age. We used a large diameter (16°) grating to measure the development of binocular grating acuity because it would stimulate a large region of V1 including both the center of vision and visual periphery. The thresholds were measured with both eyes open so neither eye received any patching that could give the other eye a competitive advantage.
Binocular acuity of normal animals (n = 3) (open black symbols) and animals that had 2 weeks MD (n = 8) (filled red symbols) developed together (Fig. 4A ). There was a lot of overlap among the animals in each group, so we plotted sigmoid functions fit to all the thresholds from normal (y ¼ 11:2 þ ðð0:3 À 11:2Þ= ð1 þ ðt=74:8Þ^12:6ÞÞ, R = 0.96, p < 0.0001) or 2 weeks MD animals (y ¼ 11:4 þ ðð0:3 À 11:4Þ=ð1 þ ðt=75:1Þ^9:4ÞÞ, R = 0.96, p < 0.0001). Those curves were almost completely overlapping and using the equations to calculate when adult acuity was reached (90% of asymptotic level) we found that normal animals reached adult binocular acuity at 89 days of age (SEM 5.6 days) and animals that had 2 weeks MD attained mature binocular acuity at 92 days of age (SEM 3.9 days) (Fig. 4D) .
The comparison between normals and 2 week MDs found similar development (Fig. 4A) and adult binocular acuities (normals, Fig. 4 . Binocular and deprived eye grating acuity after the end of deprivation. Binocular grating acuity developed similarly for normal animals (open circles, n = 3) and animals monocularly deprived for 2 weeks during the critical period (red symbols, n = 8) (A). Animals monocularly deprived from eye opening until 5 (green symbols, n = 3) (B) or 6 weeks of age (blue symbols, n = 3) initially developed like normals, but stopped earlier, and developed poor binocular acuity (C). The age at which normals and each deprivation condition reached 90% of their final asymptote (D). Comparison of final average binocular (E) and deprived eye (F) grating acuity for the group of normal animals and each deprivation condition. average = 11.1 cycles/deg., SEM 0.1 cycles/deg.; 2 week MDs, average = 11.2 cycles/deg., SEM 0.1 cycles/deg.) (Fig. 4E) . But quite a different pattern of acuity development emerged for animals deprived for longer periods. Surprisingly, the final binocular acuities for all of the 5 week and 6 week MDs were less than normal (Fig. 4B, C and E) . Initially, development of binocular acuity for 5 week and 6 week MDs followed the normal trajectory but then stopped earlier. After MD to 5 weeks binocular acuity reached mature levels at 84 days of age (SEM 2 days) and after 6 weeks MD it was earlier at 76 days of age (SEM 2 days) (Fig. 4D) . Both of those ages were earlier than normal (89 day SEM 4) or 2 week MD (92 days SEM 4) animals, suggesting that longer deprivation shortens the period for visual development. Furthermore, adult binocular acuities were 8.2 cycles/deg. (SEM 1.2 cycles/deg.) for 5 week MDs and only 4.4 cycles/deg. (SEM 1.1 cycles/deg.) for 6 week MDs, both of which were well below normal binocular acuity thresholds.
The last 10 thresholds were used to calculate the average binocular acuity and variability for each animal. We then used those data to run a repeated measures ANOVA which verified that each group had similar day-to-day variability in binocular acuity (p = 0.7). Then, we used a bootstrapping analysis to calculate the probability that binocular acuity for each deprived animal was drawn from the distribution of normal acuities. The probabilities were converted into z-scores and two-tail p values were calculated to identify deprived animals with binocular acuity that was different from normal. None of the 2 week MD animals were different from normal (all p values >0.05) but all of the animals deprived for longer (5 or 6 weeks MD) had binocular acuities that were significantly worse than normal (5 weeks MD p < 0.00001; 6 weeks MD p < 0.00001) (Fig. 4E) .
After mature binocular acuity was reached we measured deprived eye acuity for MDs and monocular acuity for normal animals. We used the bootstrap analysis to compare deprived eye acuity with normal monocular acuity and found that even the 2 week MD group had worse acuity than normal (Fig. 4F) . Deprived eye acuity of the 2 week MDs was $1 cycle/deg. worse than normal animals (normal monocular acuity, 10.7 cycles/deg., SEM 0.1 cycles/deg.; deprived eye acuity 2 weeks MD, 9.8 cycles/ deg., SEM 0.4 cycles/deg., p < 0.0001) (Fig. 4F) . Longer deprivation caused greater deprived eye acuity deficits compared with normals (deprived eye acuity 5 weeks MD, 7.7 cycles/deg., SEM 1.1 cycles/deg., p < 0.00001; 6 weeks MD, 3.4 cycles/deg., SEM 1.3 cycles/deg., p < 0.00001) (Fig. 4F) . Thus, all of the MD conditions led to acuity deficits in the deprived eye that persisted even though that eye was opened during the critical period and there had been months of daily binocular visual acuity testing.
Finally, we assessed if any of the groups had better binocular than deprived eye or monocular acuity that might suggest neural interactions leading to summation of the signals from the 2 eyes. Many visual functions have superior performance when viewed with both eyes compared to one eye (binocular summation) (Blake & Fox, 1973) and we used the bootstrap analysis to compare binocular and deprived eye (or monocular) acuities for every animal to determine if any of the groups had binocular summation. Normal animals had a small but not significant binocular superiority (average 11.1 cycles/deg.) over monocular acuity (10.7 cycles/deg.) (p > 0.05) suggesting that if normal cats have binocular summation for high contrast grating acuity then the gain is very small. There were no significant differences between binocular and deprived eye acuities for animals that had 5 or 6 weeks MD (p > 0.05). Only 2 week MDs had a modest 1 dB superiority of binocular (average = 11.2 cycles/deg., SEM 0.1 cycles/deg.) over deprived eye acuity (9.8 cycles/deg., SEM 0.4 cycles/deg.) (p < 0.01).
Measuring acuity in the center of vision revealed deficits after short and long MD
The lack of binocular acuity deficits in the 2 week MDs was puzzling because short MD causes a loss of AMPAR proteins in the central region in V1 (Fig. 2 ) similar to the loss after longer periods of MD (Beston, Jones, & Murphy, 2010) . We considered two possibilities: first, that 2 weeks MD only affects vision of the deprived eye; and second, that measuring binocular acuity with a large (16°) stimulus was masking a deficit by stimulating beyond the center of vision in V1. To address these possibilities we reassessed deprived eye and binocular acuities using a small (4°), medium (8°), or large diameter grating (16°) where the small stimulus diameter was within the cat's center of vision.
For normal animals, monocular and binocular acuities were not affected by measuring thresholds with smaller diameter stimuli (repeated-measures ANOVA p = 0.3) (Fig. 5) . In contrast, all of the MDed animals had significantly worse deprived eye and binocular acuities when measured with the smaller stimuli and the deficits grew linearly with the size of the stimulus (repeated-measures ANOVA for 2, 5 and 6 week MDs all p values <0.05). Even animals deprived for 2 weeks had significantly worse grating acuity (binocular and deprived eye) for the small (4°) and medium (8°) sized stimuli compared with the large stimulus (Fig. 5) . Using the smaller stimuli we showed that 2 weeks MD caused binocular acuity deficits of more than 2 cycles/deg. in the center of vision. Interestingly, the slopes of the linear functions fit to the binocular and deprived eye acuities were not different among the 3 groups of MDed animals (ANCOVA p = 0.5). Thus, using smaller stimuli we found that both binocular and deprived eye acuity deficits scaled linearly as the stimulus size was reduced down to the center of vision. Furthermore, the entire acuity function dropped down with longer periods of MD to the point where animals deprived to 6 weeks were left with rudimentary acuity in the center of vision. These results suggest that the impact of MD on visual acuity has 2 phases: first, a loss in the center of vision; then after long term MD a widespread loss of acuity affecting the center and visual periphery.
Discussion
In this study we asked whether the MD-induced loss of AMPAR proteins in V1 was reflected by changes in visual acuity. We studied expression of AMPAR proteins because they are tied to visual experience-dependent plasticity and feedforward processing necessary for spatial receptive field properties of V1 neurons. To relate changes in AMPAR proteins with visual acuity we studied the effects of MD in two groups: one to examine how quickly expression of AMPAR proteins changed in different regions of V1 and the second to determine the long-term consequences of MD on acuity in the center of vision. We found that just a few hours of MD caused a rapid loss of AMPAR proteins across all of V1. But after slightly longer MD (a few days) expression of AMPAR proteins recovered in the visual periphery leaving a loss only in the central region of V1. When we examined the long-term impact of MD on vision we found a greater loss of acuity in the center of vision. Furthermore, both binocular and deprived eye acuities were affected, even in animals that had only 2 weeks of MD. Our results suggest that an experience-dependent loss of AMPAR proteins in the central region of V1 contributes to amblyopic vision by affecting binocular and deprived eye high resolution spatial vision.
We used cats in this study because they have a well formed area centralis in the retina that supports a central visual field with high resolution acuity. They also have a much larger V1 than rats (Duffy, Murphy, & Jones, 1998) making it is possible to analyze multiple tissue samples from different regions of V1. In addition, the jumping stand technique allowed us to make accurate and reliable estimates of acuity thresholds, and the large number of cats (n = 17) provided confidence about the differences between normal (n = 3) and deprived animals (n = 14). Previous studies have reported lower acuities for normal cats (range 4-8 cycles/deg.), but the spacing and size of receptive fields in the area centralis predict grating acuity as high as 20 cycles/deg. (Campbell, Maffei, & Piccolino, 1973; Cleland, Harding, & Tulunay-Keesey, 1979; Cleland et al., 1980; Jacobson, Franklin, & McDonald, 1976; Robson & Enroth-Cugell, 1978; Steinberg, Reid, & Lacy, 1973) . In this study, normal cats achieved acuity thresholds of about 12 cycles/deg., consistent with a recent study that measured similarly high grating acuity thresholds in cats (Clark & Clark, 2013) . This increased sensitivity for measuring acuity, especially of normal cats, no doubt contributed to finding acuity deficits in all of the deprived animals.
We used the same technique to quantify synaptic proteins as our previous study that found a loss of AMPAR proteins in the central region of V1 after MD (Beston, Jones, & Murphy, 2010) . The Western blot technique provides good quantification of the available pool of AMPAR associated proteins. It does not, however, give an indication of cell types, layers, or the location of synaptic remodeling in V1. Anatomical studies of ocular dominance columns in cats and monkeys have shown that MD causes shrinkage of deprived eye columns and expansion of non-deprived column (Horton & Hocking, 1997; Hubel, Wiesel, & LeVay, 1977; Shatz & Stryker, 1978) . Those columnar changes reflect eye-specific remodeling of geniculocortical afferents (Antonini & Stryker, 1993 ) that occur after 7 days or longer MD (Antonini & Stryker, 1996) . In the current study, we found that the loss of AMPAR expression in the central region was similar after 1 or 7 days of MD. This constant loss of AMPARs maybe caused by dynamic changes in synaptic density. For example, the overall density of synapses on geniculocortical afferents is similar after 2 or 7 days of MD, despite significant eye-specific remodeling of the afferents over that period (Silver & Stryker, 1999) . These results suggest that AMPAR expression after a few days of MD reflects a conservation in the overall density of synapses serving the two eyes. Shorter MD, however, on a time scale of hours, causes rapid loss of dendritic spines and deprived eye responsiveness (Yu, Majewska, & Sur, 2011) . That time course matches the rapid loss of AMPAR expression in V1 found in the current study after only 6 h of MD. On the one hand, the rapid changes in dendritic spines and slower remodeling of geniculocortical afferents may be captured by dynamic changes in AMPAR expression. On the other hand, the lack of recovery of AMPAR expression in the central region may reflect reduced remodeling of afferents in that region of V1. The current results will be helpful for designing future anatomical studies to map experience-dependent changes in neural circuitry in different regions of V1.
How might the loss of AMPAR proteins contribute to amblyopic vision deficits? AMPARs mediate much of the feedforward processing that shapes the spatial properties of V1 neurons (Lamme, Supèr, & Spekreijse, 1998; Self et al., 2012) , and blocking AMPAR activity reduces the main stimulus driven response in V1 (Self et al., 2012) . The spatial properties of V1 neurons limit visual acuity (Parker & Hawken, 1985) and because AMPARs mediate the feedforward drive that shapes those receptive field properties it is reasonable to propose that a loss of AMPARs in the central region of V1 would have an adverse impact on high resolution acuity. The most direct way to test that relationship is by manipulating AMPARs either by selectively reducing AMPARs in the central region of V1 in normal cats, or by preventing the loss of AMPARs caused by MD. A challenge for those studies is that the powerful techniques for genetic manipulations of AMPARs are currently only available in rodent models, but rodents lack a well developed center of vision with high resolution acuity.
The relationship between experience-dependent loss of AMPAR proteins and visual acuity is likely to include changes in parvalbumin-positive (PV+) circuitry in V1. The dominant excitatory input to PV+ neurons is mediated by AMPAR rich synapses containing the GluA2 subunit (Kooijmans et al., 2014) , and MD reduces excitatory drive from pyramidal neurons onto binocular PV+ neurons (Kuhlman et al., 2013) . Furthermore, MD causes a loss of feedforward drive from the deprived eye and weakening of inhibitory connections affecting responsiveness to both eyes (Ma, Li, & Tao, 2013) . Since activation of PV+ neurons shapes the spatial receptive field properties of V1 neurons that underlie visual perception (Lee et al., 2012) it seems likely that PV+ neurons are a component of V1 circuitry linking AMPAR changes with visual acuity. There is a growing consensus that PV+ circuitry is pivotal for experience-dependent plasticity (Hensch, 2014) and determining if there are any regional differences in PV+ neurons after MD will be important for characterizing neural mechanisms that underlie amblyopia-like loss of visual acuity in the center of vision.
What neural mechanisms might drive experience-dependent changes in the center of vision? Two theories about the organization of V1 have influenced our understanding of the links between experience-dependent changes in neural mechanisms and visual acuity: one is that visual information in V1 is processed by repeating modules/columns that are evenly distributed across the cortex (Hubel & Wiesel, 1974) and differences in spatial vision across the visual field reflect magnification of the center of vision; the other focuses on distinct perceptual differences between central and peripheral visual fields, and proposes that high resolution acuity in the center of vision depends on specialized neural processing in the corresponding region of V1. Ocular dominance column plasticity has provided evidence for the repeating modules theory by demonstrating eye-specific physiological, anatomical, and visual changes after abnormal visual experience. For example, MD causes weak physiological responses to deprived eye stimulation (Wiesel & Hubel, 1965b) and loss of geniculocortical input to V1 (Horton & Hocking, 1997; Hubel, Wiesel, & LeVay, 1977; Shatz & Stryker, 1978) that mirrors poor acuity in the deprived eye (Dews & Wiesel, 1970 ). Yet, it has been challenging to explain the function of ocular dominance columns (Adams & Horton, 2009; Horton & Adams, 2005) and physiological plasticity in V1 is not always matched by anatomical (Silver & Stryker, 1999) or visual (Murphy & Mitchell, 1986) changes. Furthermore, it is not clear how a uniform arrangement of cortical modules might interact with magnification of the center of vision to cause regional rather than eye-specific plasticity in V1. More recently, regional differences in V1 experience-dependent plasticity have been found. These include different experience-dependent plasticity mechanisms between binocular and monocular regions in rodent V1 (Kuo & Dringenberg, 2012; Nataraj & Turrigiano, 2011) and different effects of MD, binocular deprivation, or strabismus on central versus peripheral regions in V1 of cats and monkeys (Adams et al., 2013; Beston, Jones, & Murphy, 2010; Kiorpes & Movshon, 1998; Laskowska-Macios et al., 2014; Murphy, Duffy, & Jones, 2004) . Importantly, even normal animals have differences in the pattern of ocular dominance columns in central versus peripheral regions of V1 (Anderson, Olavarria, & Van Sluyters, 1988; Horton & Hocking, 1996) .
There is good evidence that both columnar and regional plasticity mechanisms are engaged by MD but the current results indicate that regional plasticity in the center of vision dominates when deprivation extends for weeks. Monocular deprivation for longer than a week causes changes in the expression of synaptic proteins in the central region of V1 that could contribute to developmental plasticity by shifting the excitatory:inhibitory balance, accelerating receptor maturation, and reducing feedforward drive in V1 (Beston, Jones, & Murphy, 2010; Murphy, Duffy, & Jones, 2004) . Those synaptic changes are likely to disrupt development of circuitry that processes visual signals for high resolution acuity leading to abnormal neural processing and poor visual acuity in the center of vision.
What unanswered questions about amblyopia might be addressed using this animal model? In this study we found a number of acuity changes in all MDed cats including binocular acuity deficits and greater deficits in the center of vision. One of the challenges for developing an animal model of amblyopia is creating visual changes that are comparable to those found in human amblyopes. For example, acuity loss caused by MD during the critical period is typically more severe than the deficits found in human amblyopes which raises the question whether neural changes caused by MD are similar to those underlying amblyopia. Shorter periods of MD, like the 2 weeks used in this study, and other forms of abnormal visual experience (e.g., strabismus, anisometropia) in cats and monkeys lead to acuity deficits that are more similar to human amblyopes. Those models may be better suited for elucidating neural changes in V1 that could mediate greater vision deficits in the central visual field of amblyopes. Identifying the regional changes in neural circuitry will be helpful for optimizing neuroplasticity based therapies to promote recovery of high resolution spatial vision.
